Aagaard, C., Hoang, T., Dietrich, J., Cardona, P.-J., Izzo, A., Dolganov, G., Schoolnik, G.K., Cassidy, J.P., Billeskov, R. and Andersen, P. (2011) A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nature medicine17, 189.
Adamova, E., Walsh, M.C., Gosselin, D.R., Hale, K., Preissler, M.T., Graziano, R.F. and Gosselin, E.J. (2005) Enhanced antigen-specific antibody and cytokine responses when targeting antigen to human FcGAMMA receptor type I using an anti-human FcGAMMA receptor type I-streptavidin fusion protein in an adjuvant-free system. Immunological investigations34, 417-429.
Agger, E.M., Rosenkrands, I., Hansen, J., Brahimi, K., Vandahl, B.S., Aagaard, C., Werninghaus, K., Kirschning, C., Lang, R., Christensen, D., Theisen, M., Follmann, F. and Andersen, P. (2008) Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS One3, e3116.
Babaki, M.K.Z., Soleimanpour, S. and Rezaee, S.A. (2017) Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design. Microbial Pathogenesis112, 20-29.
Babaki, M.K.Z., Taghiabadi, M., Soleimanpour, S., Moghadam, M.S., Mosavat, A., Amini, A.A., Mohammadi, A. and Rezaee, S.A. (2019) Mycobacterium tuberculosis Ag85b: hfcγ1 recombinant fusion protein as a selective receptor-dependent delivery system for antigen presentation. Microbial pathogenesis129, 68-73.
Bhatt, K. and Salgame, P. (2007) Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol27, 347-362.
Cliff, J.M., Kaufmann, S.H., McShane, H., van Helden, P. and O'Garra, A. (2015) The human immune response to tuberculosis and its treatment: a view from the blood. Immunol Rev264, 88-102.
Colovos, C. and Yeates, T.O. (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci2, 1511-1519.
Czajkowsky, D.M., Hu, J., Shao, Z. and Pleass, R.J. (2012) Fc‐fusion proteins: new developments and future perspectives. EMBO molecular medicine4, 1015-1028.
Egedesø, P.J., Hansen, C.W. and Jensen, P.S. (2020) Preventing the White Death: Tuberculosis Dispensaries. The Economic Journal130, 1288-1316.
Farsiani, H., Mosavat, A., Soleimanpour, S., Sadeghian, H., Akbari Eydgahi, M.R., Ghazvini, K., Sankian, M., Aryan, E., Jamehdar, S.A. and Rezaee, S.A. (2016) Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex. Mol Biosyst12, 2189-2201.
Fatima, S., Kumari, A., Das, G. and Dwivedi, V.P. (2020) Tuberculosis vaccine: A journey from BCG to present. Life Sci252, 117594.
Forrellad, M.A., Klepp, L.I., Gioffre, A., Sabio y Garcia, J., Morbidoni, H.R., de la Paz Santangelo, M., Cataldi, A.A. and Bigi, F. (2013) Virulence factors of the Mycobacterium tuberculosis complex. Virulence4, 3-66.
Harris, J., De Haro, S.A., Master, S.S., Keane, J., Roberts, E.A., Delgado, M. and Deretic, V. (2007) T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity27, 505-517.
Henriksen-Lacey, M., Christensen, D., Bramwell, V.W., Lindenstrøm, T., Agger, E.M., Andersen, P. and Perrie, Y. (2010) Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release145, 102-108.
Huygen, K. (2014) The Immunodominant T-Cell Epitopes of the Mycolyl-Transferases of the Antigen 85 Complex of M. tuberculosis. Front Immunol5, 321.
Junker, F., Gordon, J. and Qureshi, O. (2020) Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation. Front Immunol11, 1393.
Kaufmann, S.H., Weiner, J. and von Reyn, C.F. (2017) Novel approaches to tuberculosis vaccine development. Int J Infect Dis56, 263-267.
Kebriaei, A., Derakhshan, M., Meshkat, Z., Eidgahi, M.R., Rezaee, S.A., Farsiani, H., Mosavat, A., Soleimanpour, S. and Ghazvini, K. (2016) Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis. Mol Biol Rep43, 911-922.
Keler, T., Guyre, P.M., Vitale, L.A., Sundarapandiyan, K., van De Winkel, J.G., Deo, Y.M. and Graziano, R.F. (2000) Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice. J Immunol165, 6738-6742.
Khoshnood, S., Heidary, M., Haeili, M., Drancourt, M., Darban-Sarokhalil, D., Nasiri, M.J. and Lohrasbi, V. (2018) Novel vaccine candidates against Mycobacterium tuberculosis. Int J Biol Macromol120, 180-188.
Konduru, K., Bradfute, S.B., Jacques, J., Manangeeswaran, M., Nakamura, S., Morshed, S., Wood, S.C., Bavari, S. and Kaplan, G.G. (2011) Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice. Vaccine29, 2968-2977.
Krieger, E., Joo, K., Lee, J., Lee, J., Raman, S., Thompson, J., Tyka, M., Baker, D. and Karplus, K. (2009) Improving physical realism, stereochemistry, and side‐chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins: Structure, Function, and Bioinformatics77, 114-122.
Krieger, E., Koraimann, G. and Vriend, G. (2002) Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field. Proteins: Structure, Function, and Bioinformatics47, 393-402.
Kuo, C.J., Bell, H., Hsieh, C.L., Ptak, C.P. and Chang, Y.F. (2012) Novel mycobacteria antigen 85 complex binding motif on fibronectin. J Biol Chem287, 1892-1902.
Levin, D., Golding, B., Strome, S.E. and Sauna, Z.E. (2015) Fc fusion as a platform technology: potential for modulating immunogenicity. Trends in biotechnology33, 27-34.
Lew, M.H., Norazmi, M.N. and Tye, G.J. (2020) Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC). Mol Immunol117, 54-64.
Loureiro, S., Ren, J., Phapugrangkul, P., Colaco, C.A., Bailey, C.R., Shelton, H., Molesti, E., Temperton, N.J., Barclay, W.S. and Jones, I.M. (2011) Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. J Virol85, 3010-3014.
Mahajan, N.S. and Dhawale, S. (2015) Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis. European journal of medicinal chemistry102, 243-248.
Mosavat, A., Soleimanpour, S., Farsiani, H., Sadeghian, H., Ghazvini, K., Sankian, M., Jamehdar, S.A. and Rezaee, S.A. (2016) Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Infection, Genetics and Evolution39, 163-172.
Mullen, A.C., High, F.A., Hutchins, A.S., Lee, H.W., Villarino, A.V., Livingston, D.M., Kung, A.L., Cereb, N., Yao, T.-P. and Yang, S.Y. (2001) Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science292, 1907-1910.
Pitt, J.M., Blankley, S., McShane, H. and O'Garra, A. (2013) Vaccination against tuberculosis: how can we better BCG? Microbial pathogenesis58, 2-16.
Purmohamad, A., Azimi, T., Nasiri, M.J., Goudarzi, M., Zangiabadian, M., Sedighian, H. and Fooladi, A.A.I. (2020) HIV-Tuberculous Meningitis Co-infection: A Systematic Review and Meta-analysis. Curr Pharm Biotechnol.
Rawool, D.B., Bitsaktsis, C., Li, Y., Gosselin, D.R., Lin, Y., Kurkure, N.V., Metzger, D.W. and Gosselin, E.J. (2008) Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis. The Journal of Immunology180, 5548-5557.
Reljic, R., Paul, M.J. and Arias, M.A. (2009) Cytokine therapy of tuberculosis at the crossroads. Expert Rev Respir Med3, 53-66.
Ren, W., Sun, H., Gao, G.F., Chen, J., Sun, S., Zhao, R., Gao, G., Hu, Y., Zhao, G., Chen, Y., Jin, X., Fang, F., Chen, J., Wang, Q., Gong, S., Gao, W., Sun, Y., Su, J., He, A., Cheng, X., Li, M., Xia, C., Li, M. and Sun, L. (2020) Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates. Vaccine38, 5653-5658.
Rens, C., Laval, F., Wattiez, R., Lefèvre, P., Dufrasne, F., Daffé, M. and Fontaine, V. (2018) I3-Ag85 effect on phthiodiolone dimycocerosate synthesis. Tuberculosis108, 93-95.
Sharebiani, H., Hajimiri, S., Abbasnia, S., Soleimanpour, S., Asnaashari, H., Valizadeh, N., Derakhshan, M., Pilpa, R., Firouzeh, A. and Ghazvini, K. (2020) Game Theory Applications in Host-Microbe Interactions: Mycobacterium tuberculosis infection as an example. bioRxiv, 2019.2012. 2026.888602.
Shi, X., Karkut, T., Chamankhah, M., Alting-Mees, M., Hemmingsen, S.M. and Hegedus, D. (2003) Optimal conditions for the expression of a single-chain antibody (scFv) gene in Pichia pastoris. Protein Expr Purif28, 321-330.
Soleimanpour, S., Farsiani, H., Mosavat, A., Ghazvini, K., Eydgahi, M.R., Sankian, M., Sadeghian, H., Meshkat, Z. and Rezaee, S.A. (2015) APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice. Appl Microbiol Biotechnol99, 10467-10480.
Soleimanpour, S., Hassannia, T., Motiee, M., Amini, A.A. and Rezaee, S.A. (2017) Fcγ1 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties. Crit Rev Biotechnol37, 371-392.
Tang, X.L., Zhou, Y.X., Wu, S.M., Pan, Q., Xia, B. and Zhang, X.L. (2014) CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents. J Infect69, 569-580.
Taylor, J.L., Wieczorek, A., Keyser, A.R., Grover, A., Flinkstrom, R., Karls, R.K., Bielefeldt‐Ohmann, H., Dobos, K.M. and Izzo, A.A. (2012) HspX‐mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Immunology and cell biology90, 945-954.
Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F. and Higgins, D.G. (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res25, 4876-4882.
Wang, Z., Wang, Y., Zhang, D., Li, J., Hua, Z., Du, G. and Chen, J. (2010) Enhancement of cell viability and alkaline polygalacturonate lyase production by sorbitol co-feeding with methanol in Pichia pastoris fermentation. Bioresour Technol101, 1318-1323.
Wiker, H.G. and Harboe, M. (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev56, 648-661.